Clinical trial
A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne Vulgaris
NCT02798120 is registered in ClinicalTrials.gov with Novan, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne Vulgaris
- Lead sponsor
- Novan, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 12, 2016
- Completion date
- April 27, 2017
- Enrollment
- 601 (actual)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.